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A B S T R A C T   
Lipoproteins play a central role in the development of atherosclerosis. High and low-density lipoproteins (HDL 
and LDL), known as ‘good’ and ‘bad’ cholesterol, respectively, remove and/or deposit lipids into the artery wall. 
Hence, insight into lipid exchange processes between lipoproteins and cell membranes is of particular im-
portance in understanding the onset and development of cardiovascular disease. In order to elucidate the impact 
of phospholipid tail saturation and the presence of cholesterol in cell membranes on these processes, neutron 
reflection was employed in the present investigation to follow lipid exchange with both HDL and LDL against 
model membranes. Mirroring clinical risk factors for the development of atherosclerosis, lower exchange was 
observed in the presence of cholesterol, as well as for an unsaturated phospholipid, compared to faster exchange 
when using a fully saturated phospholipid. These results highlight the importance of membrane composition on 
the interaction with lipoproteins, chiefly the saturation level of the lipids and presence of cholesterol, and 
provide novel insight into factors of importance for build-up and reversibility of atherosclerotic plaque. In ad-
dition, the correlation between the results and well-established clinical risk factors suggests that the approach 
taken can be employed also for understanding a broader set of risk factors including, e.g., effects of triglycerides 
and oxidative stress, as well as local effects of drugs on atherosclerotic plaque formation.   
1. Introduction 
Atherosclerosis is the largest killer in the west and accounted for an 
estimated 17.9 million deaths in 2016 [1]. It is a leading cause of 
cardiovascular disease (CVD), which in turn originates from the build- 
up of plaque on artery walls. This plaque build-up arises from the de-
position of lipoproteins, which are subsequently oxidised, in turn 
initiating an active inflammatory process and taken up by macro-
phages. The macrophages develop into foam cells filled with lipids and 
cholesterol, over time forming a hard plaque. If this plaque ruptures, 
blood will be exposed to thrombogenic material, which can result in a 
heart attack or stroke [2]. Although plaque formation is a complex 
process, involving not only endothelial cells but also connective tissue, 
as well as calcification and onset of oxidative and other processes [3,4], 
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lipoprotein deposition nevertheless constitutes a key initial step. De-
spite this, the initial interaction of lipoprotein particles with the 
membrane wall remains poorly understood, notably in relation to lipid 
exchange from lipoprotein to the cell membrane and vice versa. 
Lipoproteins are particle-like aggregates which consist of a core of 
cholesterol esters and triglycerides, encased by a monolayer of lipids 
and apolipoproteins [5]. Among the diverse family of lipoproteins [5], 
high- and low-density lipoproteins (HDL and LDL) are particularly 
important in atherosclerosis. HDL and LDL differ in structure, compo-
sition and their role in atherogenic processes [6]. It has been shown 
clinically that LDL deposits into artery walls, aiding the development of 
atherosclerosis, whilst HDL plays a preventive role by removing cho-
lesterol from the lipid-filled foam cells in a process known as reverse 
cholesterol transport (RCT) [7,8]. For these reasons, HDL and LDL are 
frequently referred to as ‘good’ and ‘bad’ cholesterol, respectively. 
In RCT, HDL removes free cholesterol from blood vessel walls via 
various pathways [9,10] and eventually transports it to the liver where 
it is removed from the body. An inverse relationship has been demon-
strated between RCT efficiency and the risk of CVD [10], illustrating the 
importance of this step and the role of HDL in the prevention of 
atherosclerosis. However, the situation is complex as the quantity of 
HDL alone does not determine suppression of the risk of CVD, and in-
creased levels of HDL have also been found to result in no effect [11] or 
even in an increased risk for CVD [12]. Having said that, the ratio of 
HDL to LDL is of importance [13]. This suggests that there is a delicate 
equilibrium in the transport of cholesterol and other fats in both di-
rections between the lipoproteins and the endothelial membranes, 
which determines the onset of atherosclerosis. There are also several 
other fat components important in the development of atherosclerosis, 
also transported by lipoproteins. These include triglycerides and lipids 
with either saturated or unsaturated fatty acid tails. 
Whilst the dietary guidelines for the prevention of CVD include the 
reduction of saturated fats with preference for unsaturated fats, there 
are further layers of complexity in the types of fats present in foods and 
their origin in the diet. Reflecting this, there is a striking lack of con-
sensus of whether or not dietary saturated fats can be directly corre-
lated to the development of various lipoprotein types and in turn CVD 
[14]. There is also little evidence that the presence of cholesterol in the 
diet impacts the risk of CVD [15]. 
In our previous work, we developed methodologies to quantify lipid 
exchange from model cell membranes by lipoproteins (Fig. 1) using 
both neutron reflection [16] and small angle neutron scattering [17]. 
Such methodologies allow mechanistic studies of the impact of mem-
brane composition on the capacity of lipoproteins to exchange and re-
move lipids. For example, neutron reflection results have demonstrated 
that increasing the content of negatively charged lipids in the mem-
brane (as in cancerous cells [18]) resulted in an increased removal of 
lipids from the cell membrane bilayer in both HDL and LDL systems 
[19]. This mirrors the strong interaction of LDL with negatively charged 
surfaces, mediated by electrostatic interactions with the positive re-
sidues in the ApoB protein in LDL [20], and has clinical implications 
related to calcium signalling in atherosclerotic development [21]. 
While thus showing promise as a tool for mechanistic studies of lipo-
protein-membrane exchange, these previous investigations did not ad-
dress effects of cholesterol and lipid saturation, widely important for 
atherosclerotic plaque formation, but with poorly understood under-
lying mechanisms. Considering this, we hereby employ neutron re-
flection to distinguish the effects of acyl chain saturation and the pre-
sence of cholesterol on the ability of lipoproteins to exchange lipids to/ 
from model membranes. 
2. Materials and methods 
D2O (99.9% deuterated, Sigma-Aldrich) was provided by the Institut 
Laue-Langevin, Grenoble, France and by the ISIS Neutron Source, 
Didcot, UK. MilliQ water (18.2 Ω cm−1) was used for all cleaning 
procedures and solvent preparations. Calcium chloride (CaCl2) and Tris 
buffer saline tablets were from Sigma-Aldrich. Tris buffer (50 mM Tris, 
150 mM NaCl, pH 7.4) was prepared by dissolving a tablet in H2O or 
D2O as specified by the producer. 1,2-Dimyristoyl-d54-sn-glycero-3- 
phosphocholine (dDMPC; > 99%) was from Avanti Polar Lipids 
(Alabaster, AL). 1-palmitoyl, 2-oleoyl-sn-glycero-3-phosphocholine 
(POPC) in perdeuterated form (dPOdPC, d77; overall purity 95%) and 
tail-deuterated form (dPOhPC, d67; overall purity 95%) were both 
provided by the deuteration facility at ANSTO, produced and purified 
as previously described [22]. Bradford was from Sigma while infinite 
triglyceride and cholesterol enzymatic assays were from ThermoFisher. 
2.1. D2O-matched PC production 
Selectively deuterated phosphatidylcholine (dPC) was produced as 
reported previously [23]. The Escherichia coli strain AL95 (pssA::kanR 
lacY::Tn9 camR), containing the plasmid pAC-PCSlp-Sp-Gm (ParaB-pcs 
SpR GmR), was grown in 100% deuterated minimal medium [24] with 
the incorporation of deuterated d8-glycerol, 0.2% arabinose (un-
labelled; Sigma-Aldrich) and 2 mM deuterated choline chloride (tri-
methyl-d9, 98%; Eurisotop) [23]. After incubation at 37 °C for 24 h, 
cells were harvested by centrifugation (10,000g, 20 min, 4 °C). Total 
lipids were extracted by the Bligh and Dyer method [25] and separated 
according to phospholipid head group via chromatography on a silica- 
gel column using varying ratios of chloroform and methanol [23]. 
Thin-layer chromatography was used to further characterise the 
phospholipids by comparison to known standards [26] and quantita-
tively assessed through phosphate analysis [27]. The fatty acid com-
position of the purified dPC was determined previously to be PC 16:0/ 
17:0cyc (where ‘cyc’ refers to the cyclic unsaturation, also known as 
propyl unsaturation), PC 16:0/15:0cyc and PC 16:0/18:1 in order of 
abundance [28]. 
2.2. Deuterated cholesterol production 
Perdeuterated cholesterol was produced and purified as reported 
previously [29]. The Pichia pastoris strain CBS7435 Δhis4Δku70 
Δerg5::pPpGAP-ZeocinTM-[DHCR7] Δerg6::pGAP-G418[DHCR24] was 
grown in 100% deuterated basal salts medium in the presence of d8- 
glycerol (Eurisotop). After 7 days in a fermenter at 28 °C, the batch 
phase was complete and the fed-batch phase was initiated by constant 
feeding of d8-glycerol for a further 12 days. The cells were harvested 
and then isolated using an organic solvent extraction method followed 
by HPLC to obtain pure cholesterol, verified by GCMS. 
The production of dPC and deuterated cholesterol made full use of 
the Deuteration Laboratory (D-lab) within ILL's Life Sciences Group 
[30]; this facility is widely used for in vitro production of biomolecules 
in the interests of biological neutron scattering [31–37]. 
2.3. Model membrane preparation 
Lipid films were prepared from chloroform stocks of the different PC 
lipids and cholesterol to obtain the desired compositions. Chloroform 
was evaporated under a stream of nitrogen and the resulting films 
placed under vacuum overnight. 
Prior to use, the lipid films were hydrated to a concentration of 
0.2 mg mL−1 in MilliQ water and bath sonicated for 1 h. The lipids 
were then tip sonicated for 5 min (20% power, 5 s on, 5 s off) im-
mediately before use. To optimise vesicle fusion, lipids were deposited 
at a concentration of 0.1 mg mL−1 in the presence of 2 mM CaCl2 
[38,39]; freshly tip-sonicated lipids were mixed with an equal volume 
of 4 mM CaCl2 solution [16,28], and immediately introduced into the 
solid-liquid flow cell (pre-equilibrated at 37 °C) by syringe injection. 
The lipids were incubated for 20 min before rinsing with water, fol-
lowed by 50 mM Tris saline buffer, pH 7.4. This process leads to a 
supported lipid bilayer or ‘model membrane’. 
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2.4. Lipoprotein preparation 
Lipoprotein particle preparation was carried out as described before 
[40]. Human plasma from three healthy males was purified by se-
quential ultracentrifugation resulting in isolated LDL and HDL at den-
sities of 1.019 and 1.065 g mL−1, respectively. These purified samples 
were then pooled and stored in 50% sucrose, 150 mM NaCl, 24 mM 
EDTA, pH 7.4 at −80 °C, and further fractionated via size exclusion 
chromatography at 25 °C (Superose 6 Increase 10/300 GL column, GE 
Healthcare) before use in 25 mM Tris, 150 mM NaCl at pH 7.4. Samples 
were stored at 4 °C, in an inert atmosphere away from light, ready to be 
used within one week. The Bradford assay was used to determine 
protein concentration, which in turn was used to calculate lipoprotein 
concentration. Triglyceride and total cholesterol assays were used as 
described by the manufacturer. Three different pooled preparations 
were used for various neutron experiments and the protein, trigly-
ceride, and cholesterol concentrations were used to calculate the total 
composition in mass ratio (Supporting Information, Table S1). Prior to 
injection, the lipoprotein solution was diluted to a protein concentra-
tion of 0.1 mg mL−1 for LDL and 0.132 mg mL−1 for HDL in 50 mM Tris 
saline buffer, pH 7.4. These values were chosen to ensure constant li-
poprotein particle concentration giving the same number of HDL and 
LDL particles incubating with each bilayer. The same values were also 
used in previous studies, enabling direct comparison [16,19]. Samples 
were injected into the solid liquid flow cells at 1 mL min−1 by a syringe 
pump via an injection port. The experiments were carried out at 37 °C 
to resemble the physiological environment and to ensure the fluidity of 
lipids in the model biomembrane as well as in the core in low density 
lipoprotein, the latter being solid below 20 °C [40]. 
2.5. Neutron reflectometry 
Neutron reflection data were collected on FIGARO [41,42], a time- 
of-flight reflectometer, at the Institut Laue-Langevin (Grenoble, 
France), and at INTER [43] and OFFSPEC [44], both at the ISIS Neutron 
Facility (Didcot, UK). In specular conditions, an incident neutron beam 
with wavelength, λ, is directed towards the solid/liquid interface at an 
incident angle, θ. The reflectivity as a function of the momentum 
transfer, q = 4πsin(ϴ)/λ, is measured and corresponds to the ratio of 
incident and reflected intensities. The resulting R(q) profile is linked to 
a plane-averaged scattering length density (SLD) profile perpendicular 
to the surface. SLD profiles describe the structure and composition in 
the direction perpendicular to the surface plane and can be modelled by 
a series of layers normal to the substrate characterised by a thickness, 
roughness and SLD. 
Momentum transfer ranges of 0.01  >  q  >  0.3 Å−1 were measured 
using wavelengths 2  <  λ  <  20 Å and two incident angles, 0.8° and 
2.3° on FIGARO, 1.5  <  λ  <  16 Å and 0.7° and 2.3° on INTER, and 
1.0  <  λ  <  14 Å and 0.55° and 1.8° on OFFSPEC, with a spatial re-
solution (∆q/q) of 7% at the ILL and 3% at ISIS. The area exposed to the 
neutron beam was 30 × 60 mm2. The experiments were carried out in 
reflection-up mode to ensure that any aggregated particles settled at the 
bottom of the cell, away from the surface being measured. 
The experiments were carried out using bespoke solid-liquid flow 
cells at 37 °C. The alternative experimental design of performing the 
experiments at a fixed temperature difference above the melting tran-
sition (e.g., Tm + 10 °C) of the respective lipid system was not deemed 
suitable for the present investigation due to the vastly different tran-
sition temperatures in the systems investigated. Thus, DMPC has 
Tm = 24 °C and hence the experimental temperature used here is not 
too far off Tm + 10 °C. However, Tm = −2 °C for POPC and thus 
Tm + 10 °C = 8 °C. At 8 °C, lipoproteins would behave entirely 
Fig. 1. Schematic illustration of the incubation of lipoprotein particles with the model membranes (not-to-scale: LDL is two to three times larger in diameter than 
HDL). Deuterated lipids in the model membrane can be exchanged by hydrogenated lipids from the lipoproteins and also removed via uptake by lipoproteins. 
Neutron reflection can distinguish between deuterated and hydrogenated lipids in the bilayer, and allows quantification of these processes (Cholesterol has not been 
included in the schematic illustration for clarity, since some systems contain cholesterol and others do not). 
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differently with, for example, the fluidity of the LDL core depending on 
temperature which for healthy individuals has a Tm ≈ 30 °C [40]. Thus, 
at 8 °C the core in LDL is effectively a gel, dramatically skewing ex-
change kinetics. 
The silicon (111) blocks were cleaned in Piranha solution (H2SO4/ 
H2O2, 7:3 in volume) for 10 min at 80 °C before being thoroughly rinsed 
with MilliQ water. The polyether ether ketone (PEEK) and O-ring 
components of the cells were intensively cleaned in 2% (v/v) 
Hellmanex solution twice and MilliQ water via bath sonication, with 
MilliQ rinsing between each sonication. Buffer contrasts were changed 
via HPLC pump. Contrasts used were 50 mM Tris saline buffers pre-
pared in D2O, H2O, and a mixture of 38:62 D2O:H2O in volume to 
contrast match the SLD of the silicon block (cmSi). The use of the 
deuterium isotope increases the SLD of components and can be used to 
highlight specific parts of the molecule, while the buffer contrasts allow 
differences to be seen. 
Experimental data for the bilayers in the three isotropic contrasts 
were fitted simultaneously using the MOTOFIT software [45], while the 
genetic Monte Carlo minimisation algorithm within the software was 
used to determine error estimation of the fits. Error bars are calculated 
from the error of the fit and correspond to a single measurement. In-
itially the silicon surfaces were characterised to ensure they were clean 
and to determine the thickness and roughness of the oxide layer; these 
were then fixed alongside the three solvent contrasts for fitting the 
model membranes. This resulted in a five-layer model consisting of a 
silicon oxide layer in contact with the silicon block, a small solvent 
layer, followed by the bilayer. The bilayer itself is split into 3 layers: an 
inner headgroup (closest to the silicon block), a tail region, and an outer 
headgroup exposed to the solvent. The three contrasts were fitted si-
multaneously in order to constrain the fit. The bilayer was fitted to be 
symmetrical, i.e., the thickness, SLD, and coverage of the inner and 
outer headgroups were constrained to be equal to each other during the 
fitting process, whilst the roughness was constrained to be the same 
across the whole bilayer. These initial parameters were then used as the 
starting point to fit the characterisations of the membranes after the 
incubation with the lipoprotein particles. Upon lipoprotein interaction, 
the silicon oxide layer was kept constant, while the parameters of the 
other layers were allowed to vary to accommodate the changes (details 
in Supporting Information; Tables S3 and S4). In order to obtain an 
acceptable fit and in agreement with our previous work [16], mem-
branes incubated with HDL required one extra layer while the mem-
branes incubated with LDL required two extra layers, likely due to the 
larger size of LDL over HDL. The size of the extra HDL layer and the first 
LDL layer were found to be similar (ca. 60 Å), however, the second 
layer required for the LDL fit was slightly thicker (ca. 120 Å). All 
neutron reflectivity results summarized in the figures in the main 
manuscript are also given in Supporting Information Tables S3 and S4 
to enable the reader to enjoy the specific details so that own calcula-
tions can be made. All figures on neutron reflectometry results in the 
paper are based on the data in these tables. 
3. Results 
In this work, neutron reflection was used to monitor HDL and LDL 
lipid exchange with model membranes consisting of either saturated or 
unsaturated phospholipids, both in the absence and presence of cho-
lesterol. Neutron reflection can differentiate between deuterium-la-
belled and hydrogen-rich lipids as shown schematically in Fig. 1, al-
lowing quantification of both lipid exchange and lipid removal from the 
model membranes by lipoproteins. Neutrons can thus differentiate be-
tween lipid exchanged by another lipid, and lipid replaced by solvent, 
by following the SLD change and the solvent content of the lipid tail 
region, respectively. The use of tail-deuterated lipids in a non-deuter-
ated solvent (i.e., H2O buffer) provides the best contrast to follow these 
phenomena by neutron reflection. The neutron reflection profiles were 
analysed via a layer model as described in the Materials and methods 
section. During the fitting process, the model was constrained to de-
scribe the three isotropic contrasts measured simultaneously (the bulk 
solution was exchanged from H2O buffer, to a mixture of H2O and D2O 
buffer (38% D2O), to pure D2O buffer). This increases sensitivity of the 
method and allows decoupling of lipids exchanged (deuterated mem-
brane lipids being replaced by hydrogenated lipoprotein lipids) from 
those removed (deuterated lipids removed and replaced by solvent). All 
pristine bilayers prior to incubation were found to have a surface 
coverage of 95% or more. Any minor defects below this were found not 
to influence resulting trends in lipoprotein interactions. The neutron 
reflection data, best fits, and layer models used to analyse the model 
membrane neutron reflectometry profiles can be found as Supporting 
Information (Tables S3 and S4, Figs. S1 and S2). 
3.1. Effect of phospholipid unsaturation 
Using the approach and model described above, saturated and un-
saturated model membranes were found to behave very differently in 
terms of lipid exchange. First, we compared the interaction of HDL with 
saturated and unsaturated phospholipid model membranes. The results 
show a vast difference in the relative quantity of lipids exchanged and 
removed depending on phospholipid fatty acid saturation (Fig. 2). As 
different pooled lipoprotein samples varied slightly in composition 
(Supporting Information Fig. S1), Fig. 2 shows data for each model 
membrane relative to the incubation with the dDMPC membrane for 
the same lipoprotein sample. Corresponding absolute values are found 
in Supporting Information Table S4. 
Overall, the quantities of lipids exchanged and removed were lower 
for the unsaturated phospholipids compared to the saturated phos-
pholipids, regardless of lipoprotein type. For HDL, the amount of lipids 
exchanged with the unsaturated dPC membrane was ca. 80% lower 
than for saturated dDMPC. Analogously, the quantity of lipids removed 
(and replaced by solvent), for the unsaturated dPC membrane was 
significantly reduced compared to dDMPC (ca. 90%). For LDL, in-
cubation with unsaturated dPC membranes led to a similar reduction in 
lipids exchanged as for HDL (ca. 80%). However, a smaller difference 
(ca. 60%) was observed between the saturated and unsaturated phos-
pholipids removed. The absolute quantities of lipids exchanged and 
removed for dDMPC were also lower for LDL than for HDL (Supporting 
Information, Table S4). Both types of lipoproteins display preferential 
uptake of saturated lipids as compared to unsaturated ones, although 
HDL has a greater affinity for these than LDL. This is in agreement with 
previous results, showing HDL to have a higher affinity than LDL for 
exchanging and removing saturated lipids [16]. 
3.2. Effect of cholesterol in model membranes 
Endothelial cellular membranes contain between 10 and 20 mol% of 
cholesterol [46]. Consequently, we investigated the effect of 10 or 
20 mol% cholesterol on the capacity of lipoproteins to exchange lipids 
from model membranes (Fig. 2). The presence of cholesterol reduces 
the quantity of lipids exchanged and removed by HDL. For cholesterol- 
containing saturated membranes, there was an inverse relationship 
between the quantity of lipids exchanged and the amount of cholesterol 
in the model membrane. The presence of cholesterol also reduced the 
amount of lipids removed compared to dDMPC alone. In contrast, the 
presence of cholesterol in unsaturated dPC membranes did not affect 
the extent of lipids exchanged, while the amount removed was slightly 
increased. 
A slightly different trend was observed in the presence of LDL. For 
saturated dDMPC membranes, exchange in the presence of 20 mol% 
cholesterol was comparable to that for dDMPC alone, while the quan-
tity of lipids removed decreased with increased levels of cholesterol in 
the membranes. For unsaturated dPC containing 20 mol% cholesterol, 
there was little effect on the level of lipids exchanged as compared to 
the unsaturated dPC membrane alone. However, the amount of lipids 
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removed by LDL decreased when including 20 mol% cholesterol in 
unsaturated phospholipid membranes. 
3.3. Effect of lipid exchange by LDL as a function of LDL composition 
Fig. 3 compares absolute values of lipid exchange according to li-
poprotein particle content (the fat and protein content in the HDL and 
LDL fractions hereby used are given in Supporting Information Table 
S1). As seen, an increase in lipid exchange was found with increasing 
protein content in LDL, paralleled by a decreasing total fat content 
(cholesterol and triglyceride). In contrast, no pronounced dependency 
on lipoprotein composition was seen for phospholipid removal from the 
membrane (Supporting Information Table S4). For HDL, in turn, lipo-
protein composition had only minor effects on lipids both exchanged 
and removed (Supporting Information Table S4). 
In these experiments, the protein concentration was kept constant. 
This implies that the increase in protein content across the particles 
corresponds to a decrease in particle size, assuming a constant number 
of proteins per particle [47]. Thus, smaller LDL particles seem to have 
an improved ability to exchange lipids. This is well in line with clinical 
observations, in which smaller sized LDL sub-fractions were reported to 
display higher atherosclerotic effects, which can more easily penetrate 
artery walls and become a source of fat and cholesterol for the devel-
opment of plaque [48,49]. 
3.4. Effect of headgroup deuteration on lipid exchange and removal by HDL 
Since deuteration is a pre-requisite for performing these studies, we 
investigated the effect that the degree of headgroup deuteration have 
on lipid exchange by HDL. Fig. 4 gives the percentage of lipids ex-
changed or removed by HDL in model membranes consisting of either 
dPC (composed of a mixture of unsaturated PC and cyclopropane-con-
taining PC), perdeuterated POPC (dPOdPC) or tail-deuterated POPC 
Fig. 2. Relative lipid exchange and removal for HDL or LDL particles interacting with membranes formed with saturated (dDMPC) and unsaturated (dPC) phos-
pholipids with and without cholesterol. Results are shown for HDL (A, B) and LDL (C, D) regarding exchange (A, C) and removal (B, D). 
Fig. 3. HDL-induced lipid exchange and removal, for unsaturated dPOdPC, dPC 
and dPOhPC. 
Fig. 4. Exchange of dDMPC by LDL as a function of the protein and total fat 
content of the latter. 
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(dPOhPC). These deuterated phospholipids have different levels of 
deuteration in their phosphatidylcholine groups: 100%, 78%, and 0% in 
dPOdPC, dPC, and dPOhPC, respectively. Since the experimental tem-
perature ensured full fluidity in all model membranes, the interaction 
data highlight the difference in the exchange and removal induced by 
deuteration of the headgroup of the model membranes. We found that 
the higher level of deuteration in the headgroup correlated to a stronger 
capacity of HDL to exchange lipids. However, phospholipid removal 
from the membrane (i.e., lipids being replaced by solvent) is not sig-
nificantly influenced by headgroup deuteration, all samples showing 
0.5–2.5% phospholipid removal from the model membranes. Hence, 
headgroup deuteration does have an effect on this type of exchange 
study in terms of absolute values of lipids exchanged. This can be ex-
plained by deuteration affecting bond vibrations, molecular motions 
and hydrogen bonding. Thus, we hypothesise that specific protein-lipid 
interactions are directly involved in the recognition of lipids within the 
model membrane by lipoproteins [50,51]. In particular, the minor ef-
fects observed for dPC as compared to dPOhPC could be correlated with 
this lipid having deuteration only on the amine methyl groups of the 
phosphatidylcholine headgroup [23], this amine group is not involved 
on hydrogen bonding. Even though deuteration in the headgroups 
could impact lipid-protein interactions, deuteration in the lipid tails can 
be used with no influence on the exchange data since these are not 
involved on specific interactions with apolipoproteins in LDL or HDL. 
4. Discussion 
Summarising the lipid exchange data for dDMPC with HDL and LDL 
(Table S4), and comparing these with previously reported data [19], we 
note that the absolute quantities are similar for most preparations and 
thus there is good reproducibility despite small variability in the lipo-
protein composition. For HDL, the absolute quantities of lipids removed 
and exchanged are within error to those reported by Browning et al. 
[19]. For LDL, on the other hand, we observe a dependency of lipid 
exchange with the lipoprotein composition for denser LDL (Fig. 3). 
Therefore, our results suggest that lipoproteins have similar capacities 
to exchange and remove lipids, except for LDL with total protein con-
tent lower than 30%. This implies that the pooled LDL samples (pre-
senting higher lipid exchange capacity) could be enriched in the more 
atherogenic [52], smaller and denser type of LDL, even though the 
individuals were considered to be healthy. Thus, our data may reflect 
the properties of different LDL sub-types to exchange fats [14]. This is 
the first time that differences in lipid exchange capacity have been 
reported for LDL fractions presenting distinctive compositions. 
Our data clearly show that the saturation level of the phospholipids 
present in the bilayers strongly affects the ability of lipoproteins to 
exchange and further remove lipids from model membranes (Fig. 2). 
This is seen most prominently with HDL. The difference in the ease of 
lipid removal may be attributed to protein-lipid binding affinity of HDL 
and LDL particles with the model membranes. Indeed, the conformation 
of the protein present in reconstituted HDL particles greatly impacts 
lipoprotein binding affinity for unsaturated phospholipids [53]. The 
lipoprotein particle composition may impose conformational restric-
tions on apolipoproteins, which could translate as modified binding to 
lipid molecules present in the model membranes. It may also be noted 
here that HDL therapy, based on the re-modelling of the plaque by fat- 
poor HDL, results in a decrease of both saturated fats and cholesterol in 
atherosclerotic plaque [54,55], although studies suggest that the total 
amount of HDL alone does not suppress the risk for atherosclerosis [11]. 
This highlights the need to understand which molecular properties of 
HDL contribute to its lipid exchange capacity. 
The different affinity for saturated and unsaturated phospholipids 
may be related to their different mobility. A recent inelastic neutron 
scattering study showed that saturated phospholipids have greater 
mobility both in the fluid and gel phases compared to unsaturated 
phospholipids [56]. Our data show that saturated lipids are more easily 
taken up by lipoproteins compared to unsaturated fats. Thus, lipids with 
greater mobility seem to be more accessible to lipoprotein binding, in 
turn facilitating lipid exchange. Earlier studies for lipid exchange be-
tween lipid aggregates (bicelles versus vesicles) showed that lipid ex-
change strongly depended on the length of the acyl chain as well as the 
type and size of the lipid aggregate [57]. However, these experiments 
were performed at 10 °C at which strong van der Waals interactions are 
expected. Moreover, in these experiments the molecular identity of the 
lipid aggregates did not change over time (bicelles exchange lipids with 
bicelles of the same composition or vesicles exchange lipids with ve-
sicles of the same composition). This is clearly not the case for our 
experiments where lipids from the lipoproteins (presenting a very 
complex lipid type and acyl chain composition as measured by lipi-
domics [17]), replace the model membrane lipids, and vice versa. Thus, 
the findings from the present study on increased exchange and removal 
of saturated lipids add important new insight into lipid exchange be-
tween lipoprotein and lipid membranes. 
The presence of cholesterol in the model membranes impacts the 
quantity of lipids exchanged and further removed. As with the level of 
saturation, this is most noticeable in the presence of HDL (Fig. 2). The 
normal cholesterol content in plasma membranes is 10–20 mol% [46]. 
Even though cholesterol is known to increase the order and hydro-
phobicity of membranes [46,58], differential scanning calorimetry 
(DSC) data of the model membranes hereby used (Supporting In-
formation, Fig. S3) indicate that these membranes are fluid at 37 °C, in 
agreement with literature [59]. It is possible, however, that the cho-
lesterol suppresses the mobility of saturated phospholipids to form li-
quid ordered bilayers, as previously demonstrated from in-plane dif-
fusion studies [60]. At the same time, however, cholesterol may induce 
complex local ordering and other effects as well [61], which may in-
fluence lipoprotein-membrane lipid exchange. Experimentally, we did 
not observe any systematic trends for either lipoproteins due to cho-
lesterol (Fig. 2), thus, it is unlikely that the effects observed are related 
alone to decreased mobility in the model membrane by increased 
cholesterol content. Furthermore, cholesterol molecules were reported 
to interact preferentially with saturated phospholipids [62,63]. Ad-
ditionally, LDL was shown to bind preferentially to raft domains, rich in 
saturated fats and cholesterol [64], and to modify the cell membrane 
area covered by rafts [65]. Therefore, it seems likely that specific in-
teractions between the apolipoproteins in the lipoproteins and the li-
pids in the model membrane determine the exchange of fats observed. 
We observed different lipid exchange by denser LDL (Fig. 3), suggesting 
that the properties of ApoB-100 (the main apolipoprotein in LDL) may 
be influenced by LDL density. Indeed, it was reported that small and 
medium-sized LDLs have altered epitopes between ApoB-100 residues 
4342 and 4536, as compared with VLDLs, IDLs, and large LDL [47]. The 
altered expression of these epitopes in small and medium dense LDL 
coincides with altered accessibility of protease-sensitive sites elsewhere 
in the ApoB structure [66]. These findings suggest a major change in 
the configuration of the ApoB on the LDL surface due to increased 
density. Moreover, the sequence region that includes these epitopes is 
believed to form alpha helices which are the motives found in the ex-
changeable apolipoproteins (mainly A, C, E) that are known to bind 
lipids [67]. Indeed, we showed recently that lipoprotein binding to the 
model membrane is an important step for lipid exchange, since the 
exchange via solution or via simple collision is limited [17]. Such direct 
contact might favour protein-lipid interactions. However, further stu-
dies with reconstituted lipoproteins using specific apolipoproteins are 
needed to clarify this point. 
Although debated, it has been shown that whilst dietary cholesterol 
intake does not in itself increase the risk of CVD [68], the intake of 
dietary saturated fats increases the risk of CVD [69]. Conversely, the 
replacement of saturated fats with mono- and polyunsaturated ones has 
been found to decrease the risk of CVD [70]. Such replacement has 
further been shown to lower total cholesterol, LDL cholesterol, and 
triglyceride levels in blood [70,71]: known markers for CVD risk 
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[49,72,73]. Furthermore, a diet with increased fat content has been 
shown to induce HDL production and also result in an increase in the 
total liver cholesterol content [74]. Mirroring this, our data show effi-
cient lipid removal of unsaturated phospholipids also in the presence of 
cholesterol. Therefore, cholesterol intake together with a fatty diet 
based on unsaturated fats may give rise to high HDL values despite high 
cholesterol values in the liver. In contrast, as suggested by a pro-
nounced effect of cholesterol content in saturated membranes in the 
present investigation as well as an overall large lipid exchange in the 
case of saturated phospholipids, a diet rich in saturated fats and cho-
lesterol may result not only in high cholesterol values, but also affect 
HDL exchange in atherosclerotic plaque remodelling. 
While neutron reflectivity provides novel insight on lipid exchange 
and removal on lipoprotein interactions with bilayers of different sa-
turation and cholesterol content, it should be recognized that these 
findings have been observed for highly simplified models, which ob-
viously do not fully represent the full biological system. For example, 
DMPC is present in endothelial membranes only in very small quan-
tities, and DPPC would have represented a physiologically more re-
levant lipid. However, the melting temperature of the latter lipid is 
41 °C, and DPPC is therefore not fluid at 37 °C. To use another tem-
perature than 37 °C is unsuitable not only from a physiological re-
levance perspective, but also since other temperatures might induce 
phase transition of the core in low density lipoproteins to become gel- 
like [40]. Sphingomyelin, in turn, has a high melting temperature but 
currently we lack known biosynthetic/organic approaches for its 
deuterated form. The use of DPPC or ideally sphingomyelin in combi-
nation with POPC and cholesterol can give rise to “raft like” domains 
which are of interest to study in the future due to their biological re-
levance. Furthermore, deuteration in the backbone of the phosphati-
dylcholine headgroup has some effect on lipid exchange, which also 
demonstrates a limit on to how far one should draw the comparison 
with the full biological system endorsing the use of mainly tail deut-
erated lipids instead. With such considerations in mind, however, it 
seems clear that the experimental approach taken captures key effects 
of lipid saturation and presence of cholesterol for lipoprotein-associated 
lipid exchange and removal, well suited for comparison with biological 
results of larger biological relevance, but for which mechanistic studies 
are precluded. 
5. Conclusions 
In this work, we present data of lipid exchange between pooled li-
poprotein fractions extracted from human blood (of healthy donors) 
and model membranes composed of either saturated or unsaturated 
phospholipids, in the presence or absence of cholesterol. Despite the 
simplicity of the model system, the exchange data mirror key clinical 
findings since: 1) HDL was found to remove lipids to a larger extent 
than LDL, 2) saturated fats were cleared to a larger extent by HDL than 
by LDL, while the presence of cholesterol in the membrane significantly 
reduced the ability of lipoproteins to exchange lipids, 3) lipoproteins 
present low affinity for unsaturated phospholipids which explains why 
HDL therapy is able to re-model plaque composition, and 4) denser LDL 
(with higher protein content) deposit more lipids on model membranes 
in agreement with the atherogenic characteristics of smaller and denser 
LDL sub-fractions. This suggests that the approach captures key phy-
siological aspects of atherosclerotic plaque formation, while still al-
lowing the mechanisms of lipid exchange to be investigated in detail. As 
such, it can likely be applied to unravel mechanistic information and to 
investigate other contexts relating to atherosclerosis such as LDL frac-
tions arising from patients with a defined clinical condition such as high 
cholesterol, high triglyceride, or presence of lipoprotein(A); and to 
determine the capacity of these fractions to deposit and remove fats, as 
well as systematic studies with reconstituted HDL fractions of known 
composition both in terms of lipids and apolipoproteins. 
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